PTC THERAPEUTICS TO PRESENT AT THE NORTH AMERICAN CYSTIC FIBROSIS CONFERENCE
SOUTH PLAINFIELD, NJ – October 10, 2013 – PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that the following two posters will be presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah, on October 17-19: – The use of chronic inhaled antibiotics in the phase 3 clinical trial of ataluren in […]